NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
December 17, 2025 — Neil Kelly's 2026 Home Design Trends Forecast reveals 9 key trends, including natural materials, wellness spaces, and warm colors, shaping how homeowners create grounding, restorative living environments.
December 17, 2025 — John Paul DeJoria joins PhytoTeq as advisor and investor to advance sustainable plant-based sugar technology that uses 98% less water and reduces carbon footprint.
December 17, 2025 — A leading dentist debunks dangerous home fixes for chipped teeth like superglue, outlines emergency steps, and explains modern treatments including same-day dental crowns. Learn how to protect your smile.
December 16, 2025 — American Heart Association and Eggland's Best partner to release easy, heart-healthy breakfast recipes like Turkey Bacon Quiche and Egg Muffin Cups for busy families.
December 16, 2025 — UGI Utilities warns of rising carbon monoxide emergencies, urging customers to recognize poisoning symptoms and take preventive steps for safety. Learn more here.
December 16, 2025 — Jupiter Neurosciences achieves FDA clearance for JOTROL Parkinson's trial and launches Nugevia consumer line in 2025, backed by $20M funding and celebrity endorsements.
December 16, 2025 — Annovis Bio (NYSE: ANVS) hosts a corporate update webinar on therapies for Alzheimer's and Parkinson's diseases, featuring CEO Maria Maccecchini. Learn about clinical progress and strategic direction.
December 16, 2025 — Indian researchers challenge cancer treatment norms by taming glioblastoma tumors instead of destroying them. Study shows reduced cancer biomarkers and aggressiveness, with CNS Pharmaceuticals making related progress.
December 16, 2025 — GeoVax Labs receives patent for multi-antigen vaccine platform targeting three SARS-CoV-2 proteins for broader, longer-lasting protection against evolving viruses and improved pandemic preparedness.
December 16, 2025 — Laura Merrick wins American Heart Association's 2025 Leaders of Impact award, raising $380K for CPR training and blood pressure hubs in Chicago to combat cardiac arrests.
December 16, 2025 — OYE Therapeutics raises $5.475M Series A funding for caffeine-based anesthesia recovery and opioid overdose therapy. Phase 1 clinical trial begins Q1 2026.
December 16, 2025 — American Heart Association reveals gum disease increases heart attack and stroke risk. New research shows oral health directly impacts cardiovascular wellness through inflammation pathways.
December 15, 2025 — Helix BioPharma files Q3 2025 financial statements while advancing innovative cancer treatments including L-DOS47 for NSCLC. Clinical-stage oncology company updates investors on pipeline progress.
December 15, 2025 — Healthipops launches vitamin-infused lollipops on Amazon, making children's nutrition fun and accessible nationwide. Discover healthy treats kids love.
December 15, 2025 — Oncotelic Therapeutics publishes peer-reviewed study on biomarkers in liver and pancreatic cancers, analyzing data from 7,000+ patients to advance personalized oncology treatments.
December 15, 2025 — Lionheart Health files U.S. patent for bioelectric-enhanced Klotho nanoflowers, a breakthrough platform targeting cellular aging to extend healthspan through mitochondrial repair and Klotho upregulation.
December 15, 2025 — Antisense oligonucleotides (ASOs) are revolutionizing drug development with six new FDA approvals since 2023. Oncotelic's OT-101 leads in Phase 3 trials for pancreatic cancer, offering hope against low approval rates in oncology.
December 15, 2025 — United Health Products updates FDA status on Warning Letter & releases new study data showing its CelluSTAT Hemostatic Gauze absorbs faster with less tissue reaction than standard care.
December 15, 2025 — GeoVax's GEO-CM04S1 vaccine outperforms mRNA shots in immunocompromised patients, with Phase 2 data showing superior T-cell responses and DSMB approval for exclusive trial continuation.
December 15, 2025 — American Heart Association recommends single-pill combination therapy for faster, more effective high blood pressure control, reducing heart attack and stroke risks while lowering healthcare costs.